Fast Titration Of Quetiapine Versus Currently Approved Titration

Study identifier:D1449L00003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Fast Titration Of Quetiapine Versus Currently Approved Titration: A Randomised, Multicentre, Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder

Medical condition

Psychotic Disorders

Phase

Phase 3

Healthy volunteers

Study drug

Quetiapine

Sex

All

Actual Enrollment

150

Study type

Interventional

Age

18 Years - 60 Years

Date

Study Start Date: 01 Oct 2004

Primary Completion Date: -

Study Completion Date: 01 Sept 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

AstraZeneca Clinical Trial Information – Outside US
Download
https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1798&filename=CSR-D1449L00003.pdf
Download
CSR-D1449L00003.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Norway Clinical Study Information

+47 21 00 64 00

Investigators

Principal Investigator

AstraZeneca Norway Medical Director

AstraZeneca